Loss of Fnip1 alters kidney developmental transcriptional program and synergizes with TSC1 loss to promote mTORC1 activation and renal cyst formation

被引:19
|
作者
Centini, Ryan [1 ]
Tsang, Mark [1 ]
Iwata, Terri [1 ]
Park, Heon [1 ]
Delrow, Jeffrey [2 ]
Margineantu, Daciana [3 ]
Iritani, Brandon M. [1 ]
Gu, Haiwei [4 ,6 ]
Liggitt, H. Denny [1 ]
Kang, Janella [1 ]
Kang, Lim [1 ]
Hockenbery, David M. [3 ,5 ]
Raftery, Daniel [4 ,5 ]
Iritani, Brian M. [1 ]
机构
[1] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA
[2] Fred Hutchinson Canc Res Ctr, Genom & Bioinformat Shared Resources, 1124 Columbia St, Seattle, WA 98104 USA
[3] Fred Hutchinson Canc Res Ctr, Clin Div, 1124 Columbia St, Seattle, WA 98104 USA
[4] Univ Washington, Dept Anesthesiol & Pain Med, Mitochondria & Metab Ctr, Northwest Metabol Res Ctr, Seattle, WA 98195 USA
[5] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA
[6] Arizona State Univ, Sch Nutr & Hlth Promot, Coll Hlth Solut, Ctr Metab & Vasc Biol, Phoenix, AZ USA
来源
PLOS ONE | 2018年 / 13卷 / 06期
基金
美国国家卫生研究院;
关键词
HOGG-DUBE-SYNDROME; TRANSMEMBRANE CONDUCTANCE REGULATOR; B-CELL DEVELOPMENT; PROTEIN-KINASE; TUMOR-SUPPRESSOR; POLYCYSTIC KIDNEYS; GENE-EXPRESSION; MOUSE MODEL; IN-VITRO; LYMPHOCYTE DEVELOPMENT;
D O I
10.1371/journal.pone.0197973
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Birt-Hogg-Dube' Syndrome (BHDS) is a rare genetic disorder in humans characterized by skin hamartomas, lung cysts, pneumothorax, and increased risk of renal tumors. BHDS is caused by mutations in the BHD gene, which encodes for Folliculin, a cytoplasmic adapter protein that binds to Folliculin interacting proteins-1 and-2 (Fnip1, Fnip2) as well as the master energy sensor AMP kinase (AMPK). Whereas kidney-specific deletion of the Bhd gene in mice is known to result in polycystic kidney disease (PKD) and renal cell carcinoma, the roles of Fnip1 in renal cell development and function are unclear. In this study, we utilized mice with constitutive deletion of the Fnip1 gene to show that the loss of Fnip1 is sufficient to result in renal cyst formation, which was characterized by decreased AMPK activation, increased mTOR activation, and metabolic hyperactivation. Using RNAseq, we found that Fnip1 disruption resulted in many cellular and molecular changes previously implicated in the development of PKD in humans, including alterations in the expression of ion and amino acid transporters, increased cell adhesion, and increased inflammation. Loss of Fnip1 synergized with Tsc1 loss to hyperactivate mTOR, increase Erk activation, and greatly accelerate the development of PKD. Our results collectively define roles for Fnip1 in regulating kidney development and function, and provide a model for how loss of Fnip1 contributes to PKD and perhaps renal cell carcinoma.
引用
收藏
页数:25
相关论文
共 50 条
  • [1] Loss of Tsc1, but not Pten, in renal tubular cells causes polycystic kidney disease by activating mTORC1
    Zhou, Jing
    Brugarolas, James
    Parada, Luis F.
    HUMAN MOLECULAR GENETICS, 2009, 18 (22) : 4428 - 4441
  • [2] mTORC1 Activation by Loss of Tsc1 in Myelinating Glia Causes Downregulation of Quaking and Neurofascin 155 Leading to Paranodal Domain Disorganization
    Shi, Qian
    Saifetiarova, Julia
    Taylor, Anna Marie
    Bhat, Manzoor A.
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2018, 12
  • [3] Unregulated mTORC1 activation in the liver: hepatic loss of Depdc5 and Tsc1 synergistically produces liver failure and injury
    Lee, Jun
    Cho, Chun-Seok
    Ho, Allison
    Namkoong, Sim
    Kim, Myungjin
    FASEB JOURNAL, 2020, 34
  • [4] Direct regulation of FNIP1 and FNIP2 by MEF2 sustains MTORC1 activation and tumor progression in pancreatic cancer
    Xia, Li
    Nie, Tiejian
    Lu, Fangfang
    Huang, Lu
    Shi, Xiaolong
    Ren, Dongni
    Lu, Jianjun
    Li, Xiaobin
    Xu, Tuo
    Cui, Bozhou
    Wang, Qing
    Gao, Guodong
    Yang, Qian
    AUTOPHAGY, 2024, 20 (03) : 505 - 524
  • [5] Tuberous sclerosis 1 (Tsc1) mediated mTORC1 activation promotes glycolysis in tubular epithelial cells in kidney fibrosis
    Cao, Hongdi
    Luo, Jing
    Zhang, Yu
    Mao, Xiaoming
    Wen, Ping
    Ding, Hao
    Xu, Jing
    Sun, Qi
    He, Weichun
    Dai, Chunsun
    Zen, Ke
    Zhou, Yang
    Yang, Junwei
    Jiang, Lei
    KIDNEY INTERNATIONAL, 2020, 98 (03) : 686 - 698
  • [6] TSC1 loss synergizes with KRAS activation in lung cancer development in the mouse and confers rapamycin sensitivity
    Liang, M-C
    Ma, J.
    Chen, L.
    Kozlowski, P.
    Qin, W.
    Li, D.
    Goto, J.
    Shimamura, T.
    Hayes, D. N.
    Meyerson, M.
    Kwiatkowski, D. J.
    Wong, K-K
    ONCOGENE, 2010, 29 (11) : 1588 - 1597
  • [7] Tsc1 haploinsufficiency without mammalian target of rapamycin activation is sufficient for renal cyst formation in Tsc1+/- mice
    Wilson, Catherine
    Bonnet, Cleo
    Guy, Carol
    Idziaszczyk, Shelley
    Colley, James
    Humphreys, Vikki
    Maynard, Julie
    Sampson, Julian R.
    Cheadle, Jeremy P.
    CANCER RESEARCH, 2006, 66 (16) : 7934 - 7938
  • [8] TSC1 loss synergizes with KRAS activation in lung cancer development in the mouse and confers rapamycin sensitivity
    M-C Liang
    J Ma
    L Chen
    P Kozlowski
    W Qin
    D Li
    J Goto
    T Shimamura
    D N Hayes
    M Meyerson
    D J Kwiatkowski
    K-K Wong
    Oncogene, 2010, 29 : 1588 - 1597
  • [9] BAP1 Loss Results in mTORC1 Activation in Clear Cell Renal Cell Carcinoma
    Kapur, P.
    Christie, A.
    Pena-Llopis, S.
    Margulis, V.
    Lotan, Y.
    Xie, X-J
    Brugarolas, J.
    MODERN PATHOLOGY, 2013, 26 : 223A - 223A
  • [10] BAP1 Loss Results in mTORC1 Activation in Clear Cell Renal Cell Carcinoma
    Kapur, P.
    Christie, A.
    Pena-Llopis, S.
    Margulis, V.
    Lotan, Y.
    Xie, X-J
    Brugarolas, J.
    LABORATORY INVESTIGATION, 2013, 93 : 223A - 223A